Literature DB >> 29487389

Cancer: Targeting the ubiquitin pathway.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID： 29487389     DOI： 10.1038/nrd.2018.33

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.

Authors:  Marc L Hyer; Michael A Milhollen; Jeff Ciavarri; Paul Fleming; Tary Traore; Darshan Sappal; Jessica Huck; Judy Shi; James Gavin; Jim Brownell; Yu Yang; Bradley Stringer; Robert Griffin; Frank Bruzzese; Teresa Soucy; Jennifer Duffy; Claudia Rabino; Jessica Riceberg; Kara Hoar; Anya Lublinsky; Saurabh Menon; Michael Sintchak; Nancy Bump; Sai M Pulukuri; Steve Langston; Stephen Tirrell; Mike Kuranda; Petter Veiby; John Newcomb; Ping Li; Jing Tao Wu; Josh Powe; Lawrence R Dick; Paul Greenspan; Katherine Galvin; Mark Manfredi; Chris Claiborne; Benjamin S Amidon; Neil F Bence
Journal:  Nat Med       Date:  2018-01-15       Impact factor: 53.440
  1 in total
  2 in total

1.  MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2.

Authors:  Zheng Liu; Shuyao Xiang; Xingchen Guo; Jinghuan Zhou; Lixin Liao; Jiaxin Kou; Jun Zhang
Journal:  Aging (Albany NY)       Date:  2022-02-23       Impact factor: 5.682

2.  Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.

Authors:  Jianwei Lin; Yuchen Hou; Shanzhou Huang; Ziming Wang; Chengjun Sun; Zekang Wang; Xiaoshun He; Nga Lei Tam; Chenglin Wu; Linwei Wu
Journal:  Mol Carcinog       Date:  2018-11-14       Impact factor: 4.784
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.